| circ_0067934 |
n/a |
PRKCI |
chr3:170013698-170015181:+ |
Human |
C44.9 |
Thyroid Carcinoma |
| hsa_circRNA_100410 |
hsa_circ_0015449 |
SOAT1 |
chr1:179311248-179312770:+ |
Human |
C44.9 |
Basal Cell Carcinoma |
| hsa_circRNA_100432 |
hsa_circ_0004777 |
SOX13 |
chr1:204082042-204083733:+ |
Human |
C44.9 |
Basal Cell Carcinoma |
| hsa_circRNA_100823 |
hsa_circ_0005795 |
LPXN |
chr11:58317258-58322413:- |
Human |
C44.9 |
Basal Cell Carcinoma |
| hsa_circRNA_101407/hsa_circ_0032683 |
n/a |
NEK9 |
chr14:75590748-75590926:- |
Human |
C44.9 |
Rheumatoid Arthritis |
| hsa_circRNA_102002/hsa_circ_0003505 |
n/a |
USP22 |
chr17:20910208-20911309:- |
Human |
C44.9 |
Papillary Thyroid Carcinoma |
| hsa_circRNA_102246 |
hsa_circ_0046449 |
TBCD |
chr17:80714040-80758872:+ |
Human |
C44.9 |
Basal Cell Carcinoma |
| hsa_circRNA_102612 |
hsa_circ_0005085 |
ASAP2 |
chr2:9419445-9437574:+ |
Human |
C44.9 |
Basal Cell Carcinoma |
| hsa_circRNA_103334/hsa_circ_0064996 |
n/a |
SNRK |
chr3:43341245-43373802:+ |
Human |
C44.9 |
Rheumatoid Arthritis |
| hsa_circRNA_103643 |
hsa_circ_0005912 |
FIP1 L1 |
chr4:54265896-54294350:+ |
Human |
C44.9 |
Basal Cell Carcinoma |
| hsa_circRNA_103829 |
hsa_circ_0072387 |
HMGCS1 |
chr5:43294157-43297268:- |
Human |
C44.9 |
Basal Cell Carcinoma |
| hsa_circRNA_104081 |
hsa_circ_0075825 |
LINC00340 |
chr6:21909700-22020771:+ |
Human |
C44.9 |
Basal Cell Carcinoma |
| hsa_circRNA_104083 |
hsa_circ_0075828 |
LINC00340 |
chr6:22020567-22020771:+ |
Human |
C44.9 |
Basal Cell Carcinoma |
| hsa_circRNA_104084 |
hsa_ circ_0075829 |
LINC00340 |
n/a |
Human |
C44.9 |
Basal Cell Carcinoma |
| hsa_circRNA_104370 |
hsa_circ_0080189 |
TNS3 |
chr7:47520700-47568745:- |
Human |
C44.9 |
Basal Cell Carcinoma |
| hsa_circRNA_104738 |
hsa_circ_0008732 |
BNC2 |
chr9:16727794-16738483:- |
Human |
C44.9 |
Basal Cell Carcinoma |
| hsa_circRNA_104739 |
hsa_circ_0086419 |
BNC2 |
chr9:16738357-16738483:- |
Human |
C44.9 |
Basal Cell Carcinoma |
| hsa_circ_0001370 |
hsa_circ_001830 |
YEATS2 |
chr3:183448510-183448699:- |
Human |
C44.9 |
Basal Cell Carcinoma |
| hsa_circ_0004777 |
n/a |
SOX13 |
chr1:204082042-204083733:+ |
Human |
C44.9 |
Basal Cell Carcinoma |
| hsa_circ_0005085 |
n/a |
ASAP2 |
chr2:9419445-9437574:+ |
Human |
C44.9 |
Basal Cell Carcinoma |
| hsa_circ_0005795 |
n/a |
LPXN |
chr11:58317258-58322413:- |
Human |
C44.9 |
Basal Cell Carcinoma |
| hsa_circ_0005912 |
n/a |
FIP1L1 |
chr4:54265896-54294350:+ |
Human |
C44.9 |
Basal Cell Carcinoma |
| hsa_circ_0008732 |
n/a |
BNC2 |
chr9:16727794-16738483:- |
Human |
C44.9 |
Basal Cell Carcinoma |
| hsa_circ_0015449 |
n/a |
SOAT1 |
chr1:179311248-179312770:+ |
Human |
C44.9 |
Basal Cell Carcinoma |
| hsa_circ_0046449 |
n/a |
TBCD |
chr17:80714040-80758872:+ |
Human |
C44.9 |
Basal Cell Carcinoma |
| Hsa_circ_0058124 |
n/a |
FN1 |
chr2:216270960-216274462:- |
Human |
C44.9 |
Papillary Thyroid Carcinoma |
| hsa_circ_0072387 |
n/a |
HMGCS1 |
chr5:43294157-43297268:- |
Human |
C44.9 |
Basal Cell Carcinoma |
| hsa_circ_0075825 |
n/a |
LINC00340 |
chr6:21909700-22020771:+ |
Human |
C44.9 |
Basal Cell Carcinoma |
| hsa_circ_0075828 |
n/a |
LINC00340 |
chr6:22020567-22020771:+ |
Human |
C44.9 |
Basal Cell Carcinoma |
| hsa_circ_0075829 |
n/a |
LINC00340 |
chr6:22020567-22056919:+ |
Human |
C44.9 |
Basal Cell Carcinoma |
| hsa_circ_0080189 |
n/a |
TNS3 |
chr7:47520700-47568745:- |
Human |
C44.9 |
Basal Cell Carcinoma |
| hsa_circ_0086419 |
n/a |
BNC2 |
chr9:16738357-16738483:- |
Human |
C44.9 |
Basal Cell Carcinoma |
|
